These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32242852)

  • 1. THE EFFECTIVENESS OF MELATONIN IN THE COMPLEX TREATMENT OF HYPERTENSION IN PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE.
    Petrova A; Kondratiuk V; Karpenko O; Ostashevska T; Krasiuk E
    Georgian Med News; 2020 Feb; (299):87-93. PubMed ID: 32242852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy.
    Hermida RC; Smolensky MH; Ayala DE; Fernández JR; Moyá A; Crespo JJ; Mojón A; Ríos MT; Fabbian F; Portaluppi F
    Nephrol Dial Transplant; 2014 Jun; 29(6):1160-7. PubMed ID: 24009285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.
    Sarafidis PA; Ruilope LM; Loutradis C; Gorostidi M; de la Sierra A; de la Cruz JJ; Vinyoles E; Divisón-Garrote JA; Segura J; Banegas JR
    J Hypertens; 2018 May; 36(5):1076-1085. PubMed ID: 29465710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian blood pressure patterns and blood pressure control in patients with chronic kidney disease.
    Di Daniele N; Fegatelli DA; Rovella V; Castagnola V; Gabriele M; Scuteri A
    Atherosclerosis; 2017 Dec; 267():139-145. PubMed ID: 29128778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure monitoring-based analysis of long-term outcomes for kidney disease progression.
    Ida T; Kusaba T; Kado H; Taniguchi T; Hatta T; Matoba S; Tamagaki K
    Sci Rep; 2019 Dec; 9(1):19296. PubMed ID: 31848394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal diurnal blood pressure profile and hypertension-mediated organ damage in nondiabetic chronic kidney disease G1-G3b patients.
    Stróżecki P; Pluta A; Donderski R; Włodarczyk Z; Manitius J
    Blood Press Monit; 2021 Feb; 26(1):22-29. PubMed ID: 33234809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.
    Ishigaki S; Ohashi N; Isobe S; Tsuji N; Iwakura T; Ono M; Sakao Y; Tsuji T; Kato A; Miyajima H; Yasuda H
    Clin Exp Nephrol; 2016 Dec; 20(6):878-884. PubMed ID: 26743744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of non-dipper circadian rhythm of blood pressure on left ventricular hypertrophy in patients with non-dialysis chronic kidney disease.
    Che X; Mou S; Zhang W; Zhang M; Gu L; Yan Y; Ying H; Hu C; Qian J; Ni Z
    Acta Cardiol; 2017 Apr; 72(2):149-155. PubMed ID: 28597784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of ambulatory blood pressure monitoring in chronic kidney disease: The moroccan experience.
    Asserraji M; Bouzerda A; Soukrate S; Maoujoud O; Belarbi M; Zemraoui N; Bendriss L; Khatouri A
    Saudi J Kidney Dis Transpl; 2019; 30(4):913-918. PubMed ID: 31464249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis.
    Wang C; Ye Y; Liu C; Zhou Y; Lv L; Cheng C; Li S; Lou T; Liu X
    Intern Med J; 2017 Aug; 47(8):900-906. PubMed ID: 28544243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM.
    Paoletti E; Bellino D; Amidone M; Rolla D; Cannella G
    J Nephrol; 2006; 19(6):778-82. PubMed ID: 17173252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
    Hermida RC
    Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian blood pressure variation amongst people with chronic kidney diseases: A pilot study in Ibadan.
    Adeoye AM; Raji YR; Adebiyi A; Tayo BO; Salako BL; Ogunniyi A; Ojo A; Cooper R
    Niger Postgrad Med J; 2017; 24(3):131-136. PubMed ID: 29082900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal blood pressure target and measurement in patients with chronic kidney disease.
    Kim CS; Choi HS; Bae EH; Kim SW; Ma SK
    Korean J Intern Med; 2019 Nov; 34(6):1181-1187. PubMed ID: 31189302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study.
    Covic A; Mititiuc I; Gusbeth-Tatomir P; Goldsmith DJ
    J Nephrol; 2002; 15(5):497-506. PubMed ID: 12455715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.